Company Filing History:
Years Active: 2012
Title: Gilbert Andreoletti: Innovator in Radiopharmaceutical Production
Introduction
Gilbert Andreoletti is a notable inventor based in Urville-Nacqueville, France. He has made significant contributions to the field of radiopharmaceuticals, holding 2 patents that focus on innovative processes for producing and separating radioactive elements.
Latest Patents
One of his latest patents is titled "Production of thorium 228 starting from a natural thorium salt." This invention outlines a process for producing thorium 228 from natural thorium salt through a series of steps, including the separation of radium from other radioelements. The process involves coprecipitation with barium sulfate, followed by the extraction and purification of thorium 228. This innovation has applications in the manufacture of radiopharmaceutical products, particularly in nuclear medicine for treating cancers and AIDS.
Another significant patent by Andreoletti is "Process for separating a chemical element from uranium (VI) starting from a nitric aqueous phase." This patent describes an efficient method for separating a chemical element, such as neptunium(IV) or thorium 228, from uranium in an extraction cycle. The process is particularly useful when the chemical element is present in lower concentrations than uranium.
Career Highlights
Gilbert Andreoletti is associated with Areva NC, a company known for its expertise in nuclear energy and radiopharmaceuticals. His work at Areva NC has allowed him to focus on innovative solutions in the field of nuclear medicine.
Collaborations
He has collaborated with Patrick Bourdet, contributing to advancements in radiopharmaceutical technologies.
Conclusion
Gilbert Andreoletti's contributions to the field of radiopharmaceuticals through his innovative patents highlight his role as a key inventor in this specialized area. His work continues to impact the medical field positively.